An MRI-based approach to prostate cancer diagnosis: a urologists stance in the debate
The first study illustrating the potential of MRI in the diagnosis of prostate cancer was published in 2006. Although there have since been a number of other studies showing this utility, the use of M...
Author: VJOncology
Added: 02/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Challenges for prostate cancer: overdiagnosis and unnecessary treatment
The current diagnostic methods for prostate cancer are not always as reliable or accurate as they could be, leading to mis- or over-diagnosis, and thus the treatment of patients who will not benefit f...
Author: VJOncology
Added: 02/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 12, 2018 Category: Cancer & Oncology Source Type: podcasts
MRI-based prostate cancer diagnosis: economic and logistical considerations
The take-home message from the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, on MRI for prostate cancer diagnosis was positive. However, this leaves us with a variety of questions. In th...
Author: VJOncology
Added: 02/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 12, 2018 Category: Cancer & Oncology Source Type: podcasts
MRI and MRI-directed biopsies for the diagnosis of prostate cancer
The utilization of MRI for the diagnosis of prostate cancer in men at risk is relatively new. In this interview, filmed at the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, Mark Emberton...
Author: VJOncology
Added: 02/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 12, 2018 Category: Cancer & Oncology Source Type: podcasts
This is SPARTAN! Apalutamide treatment for nmCRPC
Highly anticipated data from the Phase III SPARTAN study (NCT01946204), which investigated apalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC), was presented at the 2018 Genito...
Author: VJOncology
Added: 02/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Straightforward study design: SPARTAN trial of apalutamide for nmCRPC
There has previously been no effective treatment for nonmetastatic castration-resistant prostate cancer (nmCRPC). Now there are several exciting late-phase clinical trials investigating promising trea...
Author: VJOncology
Added: 02/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 12, 2018 Category: Cancer & Oncology Source Type: podcasts
How will the results of the SPARTAN study impact US clinical practice in prostate cancer?
The emergence of an effective treatment for nonmetastatic castration-resistant prostate cancer (nmCRPC) is likely to have a paradigm-changing effect on the treatment of CRPC. In this informative talk ...
Author: VJOncology
Added: 02/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Nonmetastatic CRPC: meeting an unmet need
Nonmetastatic castration-resistant prostate cancer (nmCRPC) is a disease which had no FDA-approved treatment. Following the completion of the Phase III SPARTAN trial (NCT01946204), a new nonsteroidal ...
Author: VJOncology
Added: 02/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Key messages on prostate cancer treatment from BOPA 2017
The British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK revealed the latest clinical updates on prostate cancer treatment. In this video, Robert Jones, MD of the Bea...
Author: VJOncology
Added: 01/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 30, 2018 Category: Cancer & Oncology Source Type: podcasts
Prostate cancer precision medicine
Targeted therapy for prostate cancer is a promising field, which is set to grow in the coming year. Here, Robert Jones, MD of the Beatson West of Scotland Cancer Centre, Glasgow, UK discusses the late...
Author: VJOncology
Added: 01/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 30, 2018 Category: Cancer & Oncology Source Type: podcasts
Exciting advances in systemic therapy for prostate cancer: docetaxel and abiraterone
The identification of effective systemic medications for prostate cancer has been relatively recent and this field is now making exciting advances. Speaking from the British Oncology Pharmacy Associat...
Author: VJOncology
Added: 01/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 30, 2018 Category: Cancer & Oncology Source Type: podcasts
Role of Surgery in Localized vs. Advanced Prostate Cancer
What is the standard of care for localized and advanced prostate cancer? Where does surgery come in to play? Learn more about what treatment options are available as Dr. Celestia Higano from Seattle C...
Author: patientpower
Added: 01/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Testosterone Therapy and PCa Risk in Hypogonadal Men
Dr Chodak reviews a ' provocative ' study on the risk for prostate cancer in men receiving testosterone therapy for hypogonadism. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - December 27, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts
Early Use of Chemotherapy for Prostate Cancer?
Dr. Susanne Osanto discusses the use of chemotherapy plus androgen deprivation therapy (ADT) for newly diagnosed men with advanced stage prostate cancer.
Author: vhsimons
Added: 12/18/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2017 Category: Cancer & Oncology Source Type: podcasts
Revolution in individualized treatment of prostate cancer
Dr. Susanne Osanto discusses the emergence of new molecular and genomic protocols to develop personalized therapies for patients both early and advanced stages.
Author: vhsimons
Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts
